Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients is a clinical trial[1].
Key Facts
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients is located in Puerto Rico[2].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients is in the country of United States[3].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's instance of is recorded as clinical trial[4].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's start time is recorded as +2006-07-31T00:00:00Z[5].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's end time is recorded as +2007-10-31T00:00:00Z[6].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's sponsor is recorded as Gilead Sciences[7].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's main subject is recorded as HIV[8].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's number of participants is recorded as {'unit': '1', 'amount': '+300'}[9].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's title is recorded as Phase IV, Open-Label, Randomized, Multicenter Study Evaluating Efficacy and Tolerability of Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir DF Compared to Unmodified HAART in HIV-1 Infected Subjects Who Have Achieved Virological Suppression on Their HAART Regimen[10].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's ClinicalTrials.gov ID is recorded as NCT00365612[12].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}[13].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's research intervention is recorded as tenofovir disoproxil[14].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's research intervention is recorded as emtricitabine[15].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's research intervention is recorded as efavirenz[16].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's clinical trial phase is recorded as phase IV clinical trial[17].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's research subject recruitment status is recorded as completed[18].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's research subject recruitment status is recorded as completed[19].
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients's study type is recorded as interventional study[20].